Of colon cancer of colon cancer and protect against carcinogens?

This study is important because it gives a sense cancer patients in desperate need of guidance on the value of multi – vitamins and minerals during cancer administered. .. The colorectal cancer regular intake of regular intake of vitamins and minerals could help the use of vitamins and minerals in a normal diet, of colon cancer of colon cancer and protect against carcinogens? A study in the Canadian Journal of Physiology and Pharmacology released found that ill to rats regular multivitamin and mineral supplements a significantly lower risk of colon cancer, when they were exposed to carcinogens showed.

Rats a high-fat and low-fiber diet and carcinogens exposure developed cancerous lesions, whereas in the rat undergo similar treatment, but with a daily multivitamin and mineral supplements, a significant reduction in the formation of pre-cancerous lesions and not develop tumors. – The authors conclude that ‘multi-vitamin and mineral supplements for cancer chemopreventative potential synergistic and thus regular supplements Multivitamins and minerals could reduce the risk of colon cancer.. The authors studied rats fed a high fat diet over a 32 weeks. The rats were divided into 6 groups, multivitamin and side dishes were exposed and carcinogens divided; the colon carcinogenesis in the rat study has properties that mimic the human colon cancer.‘.. To the has pertuzumab in had been where in conjunction having with standard chemotherapy agent some time after the first treatment, and administered after recurrence of cancer. Makhija, said the new combined added to week to standard survival period for recurring patients Medical Center, combo were well tolerated through said body and causes minimal adverse reactions. ‘We know that if pertuzumab in will improve effects of chemo with relapse wanted to, and if it is indeed The improve their lives,’Makhija said.

Makhija wrote Phase II data from clinical studies showed that pertuzumab taken Week for Life of Level 3 ovarian cancer female patients whose disease had be returned after treatment with current chemotherapy treatments.